NCT05987527View on ClinicalTrials.gov

Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

Enrolling by invitationOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

June 11, 2039

Study Completion Date

June 11, 2039

Conditions
Kidney Transplant RejectionEnd Stage Renal Disease
Interventions
DIAGNOSTIC_TEST

Blood sample

Routine procedures

Trial Locations (5)

Unknown

University Hospitals Leuven, Leuven

University Medical Center Groningen, Groningen

Leiden University Medical Centre, Leiden

Erasmus MC, University Medical Center, Rotterdam

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors
All Listed Sponsors
lead

Sangamo Therapeutics

INDUSTRY